Glucagon Kit
Product Images NDC 63323-593

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 63323-593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glu03 0002 01

Chemical sequence diagram showing the amino acid sequence of the peptide Glucagon. The sequence is presented in single-letter amino acid codes with numbered positions from 1 to 29, illustrating the primary structure of the Glucagon peptide.*

FDA Label Image

Glu03 0002 02

A line graph depicting blood glucose concentration in mg/dL over time in minutes. The graph shows two plotted curves with error bars indicating variability at each time point, and a dashed horizontal line representing a reference level. Time on the x-axis ranges from -15 to 30 minutes, and blood glucose concentration on the y-axis ranges approximately from -20 to 160 mg/dL.*

FDA Label Image

Glu03 0002 03

An instructional diagram showing components of a Glucagon injection kit by Fresenius Kabi USA. It includes a vial containing powder with a rubber stopper and orange plastic cap, an attached needle with a needle cover, and a prefilled syringe with sterile water featuring a backstop and plunger.*

FDA Label Image

Glu03 0002 04

An instructional black-and-white line drawing showing two hands preparing a vial and a syringe. One hand holds a vial while the other hand removes a cap or stopper, illustrating part of the preparation process for a medication kit.*

FDA Label Image

Glu03 0002 05

An instructional illustration showing a person's hand pulling straight off a cap from a syringe. A large black arrow points to the left with the text 'Pull Straight Off' above it, indicating the direction to remove the cap.*

FDA Label Image

Glu03 0002 06

Illustration showing a close-up of hands holding a small vial and a syringe needle, demonstrating the preparation or assembly process for injection, likely related to the Glucagon kit.*

FDA Label Image

Glu03 0002 07

An instructional illustration showing hands holding a vial and a syringe with an arrow indicating the step of drawing medication from the vial, likely part of the preparation process for the Glucagon kit by Fresenius Kabi USA, LLC.*

FDA Label Image

Glu03 0002 08

An instructional illustration showing a hand holding a cylindrical item with an arrow indicating a twisting or pulling motion. The image likely demonstrates activation or preparation steps for using a product kit, such as breaking a seal or mixing components.*

FDA Label Image

Glu03 0002 09

An instructional line drawing showing two hands preparing a syringe. The top hand holds a vial and the bottom hand is inserting a needle into the vial with a downward arrow indicating the direction of needle insertion. This illustration is likely part of administration or preparation instructions for the Glucagon kit.*

FDA Label Image

Glu03 0002 10

An instructional illustration showing two hands preparing a syringe. One hand holds the syringe with the plunger pulled back, while the other hand removes a cap from the syringe needle, indicated by a bold arrow. The image guides the assembly step of a medication kit.*

FDA Label Image

Glu03 0002 11

An instructional illustration showing a hand holding a syringe being used to draw liquid from a vial. Measurement markings of 0.5 mL and 1 mL are visible on the syringe barrel, with an arrow indicating the pull-back motion to draw up the liquid. This image likely demonstrates proper syringe usage.*

FDA Label Image

Glu03 0002 12

An instructional diagram showing the recommended injection sites for glucagon, depicted on both front and back views of a human figure. The marked areas include the thigh and upper arm on the front, and the upper arm and buttocks on the back, highlighting common intramuscular injection sites in the glucagon kit instructions.*

FDA Label Image

Glu03 0002 13

An instructional diagram showing a person administering an injection into the finger. The inset highlights the location on the finger where the injection is to be given, indicated by a black arrow. The syringe is positioned just above the puncture site, held by the person's right hand, preparing for injection into the fingertip of their left hand.*

FDA Label Image

Glu03 0002 14

An instructional illustration depicting a hand with two fingers pressing on the skin, likely demonstrating a technique for subcutaneous injection or palpation typically related to medication administration.*

FDA Label Image

Glu03 0002 15

FDA Label Image

Glu03 0002 16

Label for Glucagon for Injection (Synthetic) 1 mg per vial by Fresenius Kabi USA, LLC. This prescription drug label states it is for intramuscular or intravenous injection and diagnostic use only, with instructions to reconstitute with sterile water for injection, USP. The label includes a barcode, lot/expiration fields, and the NDC 63323-596-03.*

FDA Label Image

Glu03 0002 17

Label for Sterile Water for Injection, USP, 1 mL single dose vial, used as a drug diluent. The label includes warnings against intravenous use unless rendered nearly isotonic and states the vial contains no antimicrobial or other added substances. It is labeled for Rx use only and manufactured by Fresenius Kabi.*

FDA Label Image

Glu03 0002 18

Glucagon for Injection (Synthetic) 1 mg per vial packaging label from Fresenius Kabi USA, LLC. The label shows product details including the active ingredient glucagon hydrochloride 1 mg per vial, diluent contents, storage instructions at 20° to 25°C, and usage directions for intramuscular or intravenous injection. It includes the NDC 63323-593-03 and features the Fresenius Kabi logo and website.*

FDA Label Image

Glu03 0002 19

Label for Glucagon for Injection (Synthetic) 1 mg per vial. The label indicates the drug is for intramuscular or intravenous injection and for diagnostic use only. It instructs to reconstitute with sterile water for injection. The product is labeled by Fresenius Kabi USA, LLC.*

FDA Label Image

Glu03 0002 20

Glucagon for Injection (Synthetic) 1 mg per vial, a kit containing 10 vials for intramuscular or intravenous injection only. Label indicates it is for diagnostic use only, prescription use, and provides storage instructions. Labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.